A Bayesian Gamma-power-mixture survival regression model: predicting the recurrence of prostate cancer post-prostatectomy First version deposited in arxiv; RFS version 1.23.1.1 .
Tommy Walker Mackay, Mingtong Xu, Shahrokh F. Shariat, Roger Sewell · 2026
Read A Bayesian Gamma-power-mixture survival regression model: predicting the recurrence of prostate cancer post-prostatectomy First version deposited in arxiv; RFS version 1.23.1.1 . by Tommy Walker Mackay, Mingtong Xu, Shahrokh F. Shariat, Roger Sewell (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-25455.txt.
Introduction
Mackay and co-authors predict prostate cancer return after surgery from blood tests alone. Their Bayesian survival model reads data from 423 men who had the prostate removed. It scores how much each variable set tells about time to biochemical relapse. Age plus pre-surgery blood markers, PSA among them, carry clear signal. That set more than doubles the information an older model found. Adding grades, stage, or scan results adds nothing. Dropping the blood markers for grades or MRI cuts the signal hard. Four markers lead the ranked list.
Catalog record
| CREATOR | Tommy Walker Mackay, Mingtong Xu, Shahrokh F. Shariat, Roger Sewell |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36469 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2603.25455
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Bayesian Gamma-power-mixture survival regression model: predicting the recurrence of prostate cancer post-prostatectomy First version deposited in arxiv; RFS version 1.23.1.1 . Tommy Walker Mackay, Mingtong Xu, Shahrokh F. Shariat, Roger Sewell Abstract Acknowledgements: To Monty Barlow of Cambridge Consultants for his assistance with data access, and to Lalita Ramakrishnan for motivating the development of the model and organising funding for Tommy Walker Mackay and Mingtong Xu. Abstract We constructed a Bayesian hierarchical model for predicting the probability distribution of survival from a disease based on a number of observed explanatory variables. This model considers an unknown number of competing modes of death, each of which has a Gamma-power distribution of survival time, and each of which is active with probability given by a logistic linear regression of explanatory variables with unknown coefficients. Choosing suitable priors we applied this model to predicting recurrence time of prostate cancer following radical prostatectomy based on preoperative markers, clinical data, and operative findings, using a dataset previously collected by Shariat et al. We estimated the apparent Shannon information (ASI) in predictions based on the model on unseen patients using a variety of subsets of the available data. Results: In all the subsets examined the ASI was positive with posterior probability greater than 0.975 . Using only age and results of pre-operative blood tests (PSA and biomarkers) we achieved 0.232 (0.180 to 0.290) nats ASI (0.335 (0.260 to 0.419) bits) (posterior mean and equitailed 95% posterior confidence intervals). This is more than double the mean posterior ASI previously achieved on the same dataset by a subset of the current authors using a log-skew-Student-mixture model, and is greater than that previous value with posterior probability greater than 0.99 . Additionally using pre- or post-operative Gleason grades, operative findings, clinical stage, and presence or absence of extraprostatic extension or seminal vesicle invasion did not increase the ASI extracted. However removing the blood-based biomarkers and replacing them with either pre-operative Gleason grades or findings available from MRI scanning greatly reduced the available ASI to respectively 0.077 (0.038 to 0.120) and 0.088 (0.045 to 0.132) nats (both less than the values using blood-based biomarkers with posterior probability greater than 0.995). A greedy approach to selection of the best biomarkers gave TGF \beta_{1} , VCAM1, IL6sR, and uPA in descending order of importance from those examined. We stress that these findings apply only in a set of patients who have all undergone radical prostatectomy, and that the findings in patients taking a watchful waiting approach might be very different. 1 Introduction Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death in men in the United States [ 1 ] . Up to 30% of patients experience at least biochemical recurrence following initial therapy with curative intent. It is believed that identifying this subset of prostate cancer patients at the time of initial surgery would allow selection of a subset of patients who should receive additional therapies in the months following initial prostatectomy, thus avoiding the additional cost, inconvenience, and morbidity associated with giving all patients such additional treatment. Further, it may be possible to use such likelihood of early recurrence when choosing patient groups to enter clinical trials for novel therapies, shortening the duration of such trials by facilitating selection of those patients most likely to experience early recurrence on the basis of biomarker data. Various authors have attempted to use combinations of biomarkers and clinical data to predict which patients are at highest risk of recurrence. In particular, Shariat et al [ 2 ] collected a dataset of 423 patients with prostate cancer and analysed it using standard Cox proportional hazards methods [ 3 ] and Harrell-bootstrapped concordance [ 4 ] . Sewell et al [ 5 ] produced a Bayesian model based on log-skew-Student mixtures, and assessed it using apparent Shannon information [ 6 ] , illustrating why this is a more reliable method of assessing predictions by an algorithm than Harrell-bootstrapped concordance. However, despite being the first prediction method to produce statistically significantly positive ASI from such a dataset, the amount of ASI obtained by these authors was small (mean 0.109 nats (slightly less than one-sixth of a bit) better than a simple exponential decay prediction that is the same for all patients). Now, ASI cannot exceed the true Shannon information (TSI) available in the data about the time of relapse [ 6 ] . However it is possible for the ASI extracted by a bad algorithm to be less than the TSI available, or even to be negative (i.e. more misleading than the reference prediction), and correspondingly possible for a better algorithm to extract more ASI. Bayesian methods extract ASI equal to the TSI given the modelling and prior assumptions made – but if one model (or set of priors) reflects reality better than another, both TSI and ASI given that model may increase over those given the less accurate model. In this present paper we seek to improve on the model accuracy achieved in [ 5 ] , using a completely different, Gamma-power-mixture based survival regression model, to which we again apply Bayesian inference. In section 2 we review the background of modelling efforts, assessment of results, and previous attempts to predict relapse of prostate cancer. In section 3 we present the current model. In section 4 we describe the dataset used, and give our results in detail in section 5 before discussion and conclusion in section 6 . 2 Background 2.1 Assessment of the results of a prediction method Many papers, including [ 2 ] , have followed Harrell [ 4 ] and relied on concordance of predictions with the order of relapse of pairs of patients whose relapse order could be determined as a way of validating their predictions. Sewell showed in appendix B of [ 5 ] how Harrell’s bootstrapping can give “82% accuracy” scores to algorithms that give completely random outputs unrelated to truth; and concordance itself already relies on a small subset of the pairs of patients, often only 7% of the available pairs, for whom it is possible to determine the order of relapse (because for many pairs one will be censored before the other relapses). In consequence we need a better method of predicting the quality of a prediction of time of relapse. In [ 6 ] the Apparent Shannon Information (ASI) in a prediction about the time of relapse is put forward as an appropriate method, applying equally well to both censored and uncensored patients; an appropriate method of estimating it is also given. Given a reference probability distribution (such as an exponential decay common to all patients), the ASI scores a predicted probability distribution of relapse time by measuring the average logarithm of the factor by which that predicted probability density exceeds the reference probability density at the actual time of relapse of an unseen patient (and similarly for the ratio of the predicted probability of non-relapse by the censoring time to the reference probability of non-relapse by the censoring time). If on average that factor is 2 then the ASI is one bit; if it is a factor of e then the ASI is one nat (so that